Schering-Plough Proventil HFA
Executive Summary
Chlorofluorocarbon-free albuterol inhalation aerosol gains pediatric use indication in children four years and older for treatment or prevention of bronchospasm with approval of supplemental NDA (20-503/S-011) June 2. The product was previously approved for use in patients 12 and older